Skip to main content
Utility
Contact Us
Careers
Give
Search
Menu
Close
Main navigation
Home
About Us
toggle sub nav items
History
Careers
Training and Mentoring Program
Diversity, Equity, and Inclusion
Giving
Science and Accountability
Leadership
Faculty
toggle sub nav items
Publications
Research Areas
toggle sub nav items
B Cell
Bioinformatics and Biostatistics
Cancer Treatments
Clinical Trials
Genetic, Genomics, and Gene Regulation
Influenza
Protein Engineering
Structural Biology
Programs and Centers
toggle sub nav items
Shared Resources
Pandemic Preparedness
Collaboration for AIDS Vaccine Discovery
Product Development
Immunology Virology Quality Assessment Center
Duke Vaccine and Trials Unit
Collaborative Influenza Vaccine Innovation Centers
Duke Consortia for HIV/AIDS Vaccine Development
Duke Center for HIV Structural Biology
Duke Consortium for Innovative HIV/AIDS Vaccine and Cure Research
Diseases
toggle sub nav items
HIV/AIDS
SARS-CoV-2 (Coronavirus)
Influenza
Gonorrhea
Rotavirus
Syphilis
Tuberculosis
News and Information
toggle sub nav items
News
Announcements
Utility
Contact Us
Careers
Give
Home
Potential HIV Vaccine Component Proves Effective in Primate Study
September 9, 2022
By
Sarah Avery
Share
